TY - JOUR
T1 - 2022 ACC/AHA guideline for the diagnosis and management of aortic disease
T2 - A report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines
AU - Writing Committee Members
AU - Peer Review Committee Members
AU - AHA/ACC Joint Committee Members
AU - Isselbacher, Eric M.
AU - Preventza, Ourania
AU - Hamilton Black, James
AU - Augoustides, John G.
AU - Beck, Adam W.
AU - Bolen, Michael A.
AU - Braverman, Alan C.
AU - Bray, Bruce E.
AU - Brown-Zimmerman, Maya M.
AU - Chen, Edward P.
AU - Collins, Tyrone J.
AU - DeAnda, Abe
AU - Fanola, Christina L.
AU - Girardi, Leonard N.
AU - Hicks, Caitlin W.
AU - Hui, Dawn S.
AU - Schuyler Jones, William
AU - Kalahasti, Vidyasagar
AU - Kim, Karen M.
AU - Milewicz, Dianna M.
AU - Oderich, Gustavo S.
AU - Ogbechie, Laura
AU - Promes, Susan B.
AU - Ross, Elsie Gyang
AU - Schermerhorn, Marc L.
AU - Singleton Times, Sabrina
AU - Tseng, Elaine E.
AU - Wang, Grace J.
AU - Woo, Y. Joseph
AU - Faxon, David P.
AU - Upchurch, Gilbert R.
AU - Aday, Aaron W.
AU - Azizzadeh, Ali
AU - Boisen, Michael
AU - Hawkins, Beau
AU - Kramer, Christopher M.
AU - Luc, Jessica G.Y.
AU - MacGillivray, Thomas E.
AU - Malaisrie, S. Christopher
AU - Osteen, Kathryn
AU - Patel, Himanshu J.
AU - Patel, Parag J.
AU - Popescu, Wanda M.
AU - Rodriguez, Evelio
AU - Sorber, Rebecca
AU - Tsao, Philip S.
AU - Santos Volgman, Annabelle
AU - Beckman, Joshua A.
AU - Otto, Catherine M.
AU - O'Gara, Patrick T.
N1 - Publisher Copyright:
© 2022 American College of Cardiology Foundation and the American Heart Association, Inc. Published by Elsevier
PY - 2023/11
Y1 - 2023/11
N2 - Aim: The “2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease” provides recommendations to guide clinicians in the diagnosis, genetic evaluation and family screening, medical therapy, endovascular and surgical treatment, and long-term surveillance of patients with aortic disease across its multiple clinical presentation subsets (ie, asymptomatic, stable symptomatic, and acute aortic syndromes). Methods: A comprehensive literature search was conducted from January 2021 to April 2021, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, the Cochrane Library, CINHL Complete, and other selected databases relevant to this guideline. Additional relevant studies, published through June 2022 during the guideline writing process, were also considered by the writing committee, where appropriate. Structure: Recommendations from previously published AHA/ACC guidelines on thoracic aortic disease, peripheral artery disease, and bicuspid aortic valve disease have been updated with new evidence to guide clinicians. In addition, new recommendations addressing comprehensive care for patients with aortic disease have been developed. There is added emphasis on the role of shared decision making, especially in the management of patients with aortic disease both before and during pregnancy. The is also an increased emphasis on the importance of institutional interventional volume and multidisciplinary aortic team expertise in the care of patients with aortic disease.
AB - Aim: The “2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease” provides recommendations to guide clinicians in the diagnosis, genetic evaluation and family screening, medical therapy, endovascular and surgical treatment, and long-term surveillance of patients with aortic disease across its multiple clinical presentation subsets (ie, asymptomatic, stable symptomatic, and acute aortic syndromes). Methods: A comprehensive literature search was conducted from January 2021 to April 2021, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, the Cochrane Library, CINHL Complete, and other selected databases relevant to this guideline. Additional relevant studies, published through June 2022 during the guideline writing process, were also considered by the writing committee, where appropriate. Structure: Recommendations from previously published AHA/ACC guidelines on thoracic aortic disease, peripheral artery disease, and bicuspid aortic valve disease have been updated with new evidence to guide clinicians. In addition, new recommendations addressing comprehensive care for patients with aortic disease have been developed. There is added emphasis on the role of shared decision making, especially in the management of patients with aortic disease both before and during pregnancy. The is also an increased emphasis on the importance of institutional interventional volume and multidisciplinary aortic team expertise in the care of patients with aortic disease.
KW - ACC/AHA Clinical Practice Guidelines
KW - abdominal aortic aneurysm
KW - aortic dissection
KW - aortitis
KW - aortopathy
KW - bicuspid aortic valve
KW - blunt traumatic aortic injury
KW - cardiac surgery
KW - endovascular aortic repair
KW - guidelines
KW - heritable thoracic aortic disease
KW - intramural hematoma
KW - loeys-dietz syndrome
KW - malperfusion syndrome
KW - marfan syndrome
KW - penetrating atherosclerotic ulcer
KW - thoracic aortic aneurysm
KW - thoracic endovascular aortic repair
KW - thoracoabdominal aortic aneurysm
KW - vascular surgery
UR - http://www.scopus.com/inward/record.url?scp=85163874138&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85163874138&partnerID=8YFLogxK
U2 - 10.1016/j.jtcvs.2023.04.023
DO - 10.1016/j.jtcvs.2023.04.023
M3 - Article
AN - SCOPUS:85163874138
SN - 0022-5223
VL - 166
SP - e182-e331
JO - Journal of Thoracic and Cardiovascular Surgery
JF - Journal of Thoracic and Cardiovascular Surgery
IS - 5
ER -